Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization. - Wikidata - wikimedia - TriplyDB

Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization.

Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization.

http://www.wikidata.org/entity/Q34037141

about

Olfactory deficits in Niemann-Pick type C1 (NPC1) disease Neuropsychiatric characteristics of GBA-associated Parkinson disease.Cognitive and Antipsychotic Medication Use in Monoallelic GBA-Related Parkinson Disease.Parkinson disease in Gaucher disease.The link between the GBA gene and parkinsonism Hyposmia and cognitive impairment in Gaucher disease patients and carriers Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?Substantia nigra hyperechogenicity with LRRK2 G2019S mutations Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.Olfactory dysfunction in LRRK2 G2019S mutation carriers Exploring the link between glucocerebrosidase mutations and parkinsonism The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow Olfaction in Parkinson's disease and related disorders.Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson disease Clinical course and prognosis in patients with Gaucher disease and parkinsonism A Personalized Approach to Parkinson's Disease Patients Based on Founder Mutation Analysis A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.Autosomal recessive mutations in the development of Parkinson's disease.Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.Parkinson's disease, proteins, and prions: milestones.Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.The association between ß-glucocerebrosidase mutations and parkinsonism Glucocerebrosidase mutations and the pathogenesis of Parkinson disease.Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.New Directions in Gaucher Disease.The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers.Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease Dual-Task Performance in GBA Parkinson's Disease.Clinical, genetic, and brain sonographic features related to Parkinson's disease in Gaucher disease.Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism.

P2860

Q27300721-8D4D8F59-4BD1-4713-9316-4195D7873991 Q30275630-790244D2-804E-4F16-B756-101D63A6C16E Q30409165-6B118210-083C-47EB-B340-D137521CFEEE Q30852543-1747E761-699D-4469-BFB3-483515B333C8 Q34077492-D7DD4B13-C406-48C8-9D43-897AFB140D29 Q34300690-0BCC58BD-324F-429E-B377-F308B793D20A Q34562789-F04A0B40-CA57-430B-913C-FABDE2D0C111 Q34861140-2830D25F-AE46-4DAE-A60D-7686243F1D9F Q35079812-2C59A91B-F943-4643-8355-F93C76AD3C13 Q35119617-B9024C99-30EE-42AF-A784-C5470AE01FF3 Q35955350-AD1321C8-2BC1-421B-9389-102715074DED Q36124421-C38E79AF-CE98-40CD-BA5D-8D35FB34F3AD Q36193915-3554D729-9891-4FFF-B1CB-3AA9D01C0DD2 Q36595145-F6584594-A3AF-4A3B-86C0-8891F6864AD9 Q36794066-E1D51C6B-9865-4155-9D05-ADE2D4856C0D Q36885946-40F9C5B9-5527-428B-9ACD-99AB795C63B1 Q37096051-DCF94E55-A6E7-41AC-A089-5643A54B4B80 Q37800102-E3DD4DFC-65D9-45D9-BDB5-C53C0089BDD5 Q37880734-F0ED0E71-77ED-483B-A435-35557BB84D1F Q37882593-2AA552CE-286F-4333-A8AC-83061932CEF5 Q38003065-BC5D33B0-9D2E-458C-AB72-8150406CE2E9 Q38118169-1FC35166-7D01-487D-AE8A-3D6AD423BFBE Q38161987-69662A36-89EF-4A81-B5EB-DA30378DC556 Q38727638-94259A00-69ED-41F9-908C-27BF813E7BF4 Q38905996-E4F86D3C-2073-496D-B498-00067C9CF0A1 Q39052041-D2C4D203-11E9-4E39-A724-6B5FC479CB7D Q40114382-5FAE9ACC-2A8D-4C83-A487-5B1D76104DDF Q40994106-2357FF99-D902-4190-B688-9B515CBD7032 Q41341655-0D0A598D-64DE-4CA4-8D3E-D7BB9BB8D211 Q45245196-3293F9E2-5481-49B5-A25E-8898DFDDC2B9 Q48248911-A88BDBD0-A933-47F1-9BF6-84A822411E58

P2860

Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization.

http://www.wikidata.org/entity/Q34037141

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Gaucher disease ascertained th ...... and clinical characterization.

@ast

Gaucher disease ascertained th ...... and clinical characterization.

@en

Gaucher disease ascertained th ...... and clinical characterization.

@nl

type

label

Gaucher disease ascertained th ...... and clinical characterization.

@ast

Gaucher disease ascertained th ...... and clinical characterization.

@en

Gaucher disease ascertained th ...... and clinical characterization.

@nl

prefLabel

Gaucher disease ascertained th ...... and clinical characterization.

@ast

Gaucher disease ascertained th ...... and clinical characterization.

@en

Gaucher disease ascertained th ...... and clinical characterization.

@nl

P1433

Q34037141-B80D2259-0A6A-4893-A59D-77545874C6E0

P1476

Q34037141-08094E90-469D-484A-9BFA-6B63204D478C

P2093

Q34037141-1AF85002-B141-4B87-948B-6BD14384777C

Q34037141-3179B21C-3979-4321-B9CD-2D9A76443840

Q34037141-43A84DDD-9AEB-44DE-AA01-BB469F5F5669

Q34037141-4D2398C2-2D01-4CA0-8A53-6B125C13B9A7

Q34037141-79779E36-BE6C-443B-9C79-8B3023FBFF47

Q34037141-79824378-51AB-42C5-A85A-6BC3E37D7442

Q34037141-828E71B3-2E45-419A-8A55-685AEAA81DAA

Q34037141-8E3E19B7-1540-4ADF-94B0-080A385ECDB0

Q34037141-9D709F09-03DF-4914-9CDF-71E92017195D

Q34037141-A567D5E0-D5E6-427C-845F-E63984A4991A

P2860

Q34037141-00099BFB-B8F5-4D4C-AD03-981874573ADE

Q34037141-02F10B2D-A09F-404F-BDC4-FD61B2374719

Q34037141-0F3BBD04-0E00-42AF-93E7-B38BE4D1573A

Q34037141-1AA1AACE-4D29-453B-A6DF-AB3E3FD5EE12

Q34037141-2713C864-FCB8-49A0-8D1B-2E84A8AEC8E9

Q34037141-2C05EA1E-FC73-49B0-A0D7-D389A69D1FD0

Q34037141-407CB3A3-AF4B-4941-ABB8-0AA4FE2F5C2D

Q34037141-48708DB4-EC65-4254-8F23-931A1FEE84D2

Q34037141-48B25365-B99C-4EAE-ADF0-E032B2D90F95

Q34037141-49FE099F-7952-455D-AEA8-94850A3ABFD6

P304

Q34037141-3BFEACBE-0947-47DE-B6BD-2049227B0687

P31

Q34037141-0197AC05-6896-415F-9613-F6F7579C728D

P356

Q34037141-01975EB5-1CA5-473D-9DB5-CC857530E081

P407

Q34037141-41A549A8-FE9B-429C-946F-2EAD7FFC65B6

P433

Q34037141-A823BC46-E4B4-4133-9036-11927722EED4

P478

Q34037141-94879155-5725-4674-A801-69ECEFB88019

P50

Q34037141-19C62ABE-4541-4735-8723-48DB49EC689F

Q34037141-CABA45AF-C5B7-4469-810F-985314C5755A

P577

Q34037141-07F21D78-B269-41F5-88A5-405391922064

P5875

Q34037141-C7CF51D6-D6BD-4EF6-95DD-AA53F807AA4C

P698

Q34037141-E269E82C-F714-481A-8E14-6C53EF885DC4

P921

Q34037141-7774DA7C-9FFF-4736-862F-FCD0C423D8FE

P932

Q34037141-51075531-8D5E-4E75-85A5-CA1B10AC2820

P356

P1433

Movement Disorders

P1476

Gaucher disease ascertained th ...... and clinical characterization.

@en

P2093

Am Roe

http://www.w3.org/2001/XMLSchema#string

Christina Palmese

http://www.w3.org/2001/XMLSchema#string

Gregory Pastores

http://www.w3.org/2001/XMLSchema#string

Johann Hagenah

http://www.w3.org/2001/XMLSchema#string

Kaili Stanley

http://www.w3.org/2001/XMLSchema#string

Kelly Condefer

http://www.w3.org/2001/XMLSchema#string

Laurie Ozelius

http://www.w3.org/2001/XMLSchema#string

Michele Tagliati

http://www.w3.org/2001/XMLSchema#string

Norbert Brüggemann

http://www.w3.org/2001/XMLSchema#string

Ruth Kornreich

http://www.w3.org/2001/XMLSchema#string

P2860

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease

Staging of brain pathology related to sporadic Parkinson's disease

Glucocerebrosidase mutations in subjects with parkinsonism

Parkinsonism: onset, progression and mortality

Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease

Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound.

Normative data for equivalent, parallel forms of the Judgment of Line Orientation Test.

[Neurological manifestations of type 1 Gaucher's disease: Is a revision of disease classification needed?]

Neurological involvement in type 1 (adult) Gaucher's disease.

Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.

P304

1364-1372

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.23046

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Christine Klein

Rachel Saunders-Pullman

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45186364

http://www.w3.org/2001/XMLSchema#string

P698

20629126

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

2914177

http://www.w3.org/2001/XMLSchema#string